IL-1 antagonists (Millennium)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameIL-1 antagonists (Millennium)
Drug Alias NameIL1-RP2 (Millennium)IL-1ra homolog (Millennium)IL1-RP2
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin-1 receptor antagonists
TargetsInterleukin-1 receptor
Therapy Area/IndicationsInflammatory Bowel DiseasesColitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMillennium Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMillennium Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsInflammatory Bowel DiseasesColitis

Other Information

ATC CodeN/A
Related LinksN/A